Form 4 Tracker
Pacira BioSciences, Inc.
PCRX

29 insider filings · Latest: Jun 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 17, 2026Aug 17 3:54 PMSLONIN JONATHAN
Proposed Sale
3,040$23.23$70.6K

View →

Jun 11, 2026Jun 13 1:07 AMLauren RikerSenior Vice President, Finance
Sale
6,115$23.50$143.7K62,284.242(D)

View →

Jun 12, 2026Jun 12 4:15 PMCeesay Abraham
Proposed Sale
9,039$23.27$210.4K

View →

Jun 11, 2026Jun 11 3:28 PMRIKER LAUREN
Proposed Sale
6,115$23.50$143.7K

View →

Jun 4, 2026Jun 5 9:57 PMKristen WilliamsChief Administrative Officer
Sale
10,259$22.27$228.5K167,062(D)

View →

Jun 4, 2026Jun 4 1:48 PMWILLIAMS KRISTEN
Proposed Sale
10,259$22.27$228.5K

View →

Apr 23, 2026Apr 25 12:41 AMShawn CrossChief Financial Officer
Sale
12,941$25.16$325.6K105,341(D)

View →

Apr 23, 2026Apr 23 8:41 PMCross Shawn
Proposed Sale
12,941$25.16$325.6K

View →

Apr 22, 2026Apr 23 12:03 AMShawn CrossChief Financial Officer
Sale
1,500$25.01$37.5K105,341(D)

View →

Apr 21, 2026Apr 23 12:03 AMShawn CrossChief Financial Officer
Sale
2,845$25.01$71.2K105,341(D)

View →

Apr 20, 2026Apr 23 12:03 AMShawn CrossChief Financial Officer
Sale
7,714$25.14$193.9K105,341(D)

View →

Apr 22, 2026Apr 22 8:20 PMCross Shawn
Proposed Sale
1,500$25.01$37.5K

View →

Apr 21, 2026Apr 21 8:20 PMCross Shawn
Proposed Sale
2,845$25.01$71.1K

View →

Apr 20, 2026Apr 20 8:11 PMCross Shawn
Proposed Sale
7,714$25.14$193.9K

View →

Mar 17, 2026Mar 19 9:43 PMJonathan SloninChief Medical Officer
Sale
3,261$22.82$74.4K223,640.175(D)

View →

Mar 17, 2026Mar 19 9:43 PMMark FroimsonDirector
Sale
500$21.81$10.9K20,136(D)

View →

Mar 17, 2026Mar 17 6:55 PMFroimson Mark
Proposed Sale
500$21.81$10.9K

View →

Mar 17, 2026Mar 17 3:12 PMSLONIN JONATHAN
Proposed Sale
3,261$22.82$74.4K

View →

Feb 2, 2026Feb 3 11:24 PMLauren RikerSenior Vice President, Finance
Sale
4,000$20.81$83.2K52,313.242(D)

View →

Feb 2, 2026Feb 3 11:24 PMKristen WilliamsChief Administrative Officer
Sale
13,137$20.53$269.7K131,303(D)

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 10, 2026Jun 13 1:07 AMSamit HirawatDirector
Grant/Award
10,891$23.4210,891(D)

View →

Jun 10, 2026Jun 13 1:07 AMChristopher ChristieDirector
Grant/Award
10,891$23.4210,891(D)

View →

Jun 10, 2026Jun 13 1:07 AMThomas G WiggansDirector
Grant/Award
32,675$23.4232,675(D)

View →

Jun 10, 2026Jun 13 1:07 AMAlethia YoungDirector
Grant/Award
10,891$23.4210,891(D)

View →

Jun 10, 2026Jun 13 1:07 AMMichael J. YangDirector
Grant/Award
10,891$23.4210,891(D)

View →

Jun 10, 2026Jun 13 1:07 AMMarcelo BigalDirector
Grant/Award
10,891$23.4210,891(D)

View →

Jun 10, 2026Jun 13 1:06 AMMark FroimsonDirector
Grant/Award
10,891$23.4210,891(D)

View →

Jun 10, 2026Jun 13 1:06 AMLaura BregeDirector
Grant/Award
10,891$23.4210,891(D)

View →

Apr 23, 2026Apr 25 12:41 AMShawn CrossChief Financial Officer
Option Exercise
12,941$16.45150,000(D)

View →

Apr 22, 2026Apr 23 12:03 AMShawn CrossChief Financial Officer
Option Exercise
1,500$16.45162,941(D)

View →

Apr 21, 2026Apr 23 12:03 AMShawn CrossChief Financial Officer
Option Exercise
2,845$16.45164,441(D)

View →

Apr 20, 2026Apr 23 12:03 AMShawn CrossChief Financial Officer
Option Exercise
7,714$16.45167,286(D)

View →

Jan 27, 2026Jan 29 9:57 PMSamit HirawatDirector
Grant/Award
39,291$19.8539,291(D)

View →